Huawei's 2022 Revenue Steady At $91.5 Billion As U.S. Sanctions Impact Wanes

Huawei’s 2022 Revenue Steady At $91.5 Billion As U.S. Sanctions Impact Wanes

SHANGHAI (Reuters) -Chinese tech giant Huawei Technologies Co Ltd estimated on Friday its 2022 revenue grew 0.4% annually, suggesting that its sales decline due to U.S. sanctions had come to a halt. Despite revenue increasing only marginally, rotating chairman Eric Xu struck an upbeat tone in the company’s annual New Year’s letter, where he revealed…

Read More
Congressional Report: U.S. FDA Broke Own Protocols In Approving Biogen Alzheimer's Drug

Congressional Report: U.S. FDA Broke Own Protocols In Approving Biogen Alzheimer’s Drug

By Ahmed Aboulenein WASHINGTON (Reuters) – The U.S. Food and Drug Administration failed to adhere to its own guidance and internal practices during the approval process for Biogen’s Alzheimer’s drug Aduhelm, which was “rife with irregularities,” a congressional report showed on Thursday. The FDA’s interactions with Biogen were “atypical” and did not follow the agency’s…

Read More